CoChat

Recurrent Moderate Hypoglycemia Ameliorates Brain Damage and Cognitive Dysfunction Induced by Severe Hypoglycemia

Open access

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Although intensive glycemic control achieved with insulin therapy increases the incidence of both moderate and severe hypoglycemia, clinical reports of cognitive impairment due to severe hypoglycemia have been highly variable. It was hypothesized that recurrent moderate hypoglycemia preconditions the brain and protects against damage caused by severe hypoglycemia. RESEARCH DESIGN AND METHODS: Nine-week-old male Sprague-Dawley rats were subjected to either 3 consecutive days of recurrent moderate (25–40 mg/dl) hypoglycemia (RH) or saline injections. On the fourth day, rats were subjected to a hyperinsulinemic (0.2 units · kg−1 · min−1) severe hypoglycemic (∼11 mg/dl) clamp for 60 or 90 min. Neuronal damage was subsequently assessed by hematoxylin-eosin and Fluoro-Jade B staining. The functional significance of severe hypoglycemia–induced brain damage was evaluated by motor and cognitive testing. RESULTS: Severe hypoglycemia induced brain damage and striking deficits in spatial learning and memory. Rats subjected to recurrent moderate hypoglycemia had 62–74% less brain cell death and were protected from most of these cognitive disturbances. CONCLUSIONS: Antecedent recurrent moderate hypoglycemia preconditioned the brain and markedly limited both the extent of severe hypoglycemia–induced neuronal damage and associated cognitive impairment. In conclusion, changes brought about by recurrent moderate hypoglycemia can be viewed, paradoxically, as providing a beneficial adaptive response in that there is mitigation against severe hypoglycemia–induced brain damage and cognitive dysfunction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db09-1495

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Experimental protocol. Arterial and venous catheters were implanted into 9-week-old Sprague-Dawley rats. After 1 week of recovery, animals were either given an insulin injection daily for 3 consecutive days to induce moderate hypoglycemia (25–40 mg/dl) or they were given saline injections as a control. On the fourth day, rats underwent a severe hypoglycemic (10–15 mg/dl) hyperinsulinemic (0.2 units · kg−1 · min−1) clamp for either 60 or 90 min or, alternatively, underwent a 90-min euglycemic (∼80 mg/dl) hyperinsulinemic (0.2 units · kg−1 · min−1) clamp. Animals were either killed 1 week later to assess neuronal damage by H-E and Fluoro-Jade B staining or underwent sensorimotor and cognitive testing 6–8 weeks following the clamp.
FIG. 1. Experimental protocol. Arterial and venous catheters were implanted into 9-week-old Sprague-Dawley rats. After 1 week of recovery, animals were either given an insulin injection daily for 3 consecutive days to induce moderate hypoglycemia (25–40 mg/dl) or they were given saline injections as a control. On the fourth day, rats underwent a severe hypoglycemic (10–15 mg/dl) hyperinsulinemic (0.2 units · kg−1 · min−1) clamp for either 60 or 90 min or, alternatively, underwent a 90-min euglycemic (∼80 mg/dl) hyperinsulinemic (0.2 units · kg−1 · min−1) clamp. Animals were either killed 1 week later to assess neuronal damage by H-E and Fluoro-Jade B staining or underwent sensorimotor and cognitive testing 6–8 weeks following the clamp.CC BY-NC-ND · PubMed Central
FIG. 2. Recurrent hypoglycemia attenuates brain damage after 60 min of severe hypoglycemia. A: Blood glucose levels are shown in rats subjected to a 60-min severe hypoglycemic (10–15 mg/dl) hyperinsulinemic (0.2 units · kg−1 · min−1) clamp. Blood glucose was not significantly different between CON-SH6 (open circles) (n = 6) and RH-SH60 (closed circles) (n = 10) rats during 60 min of severe hypoglycemia. B: Representative H-E (top panel) and Fluoro-Jade B–positive (bottom panel) staining of the cortex of CON-SH60 and RH-SH60 rats 1 week following 60 min of severe hypoglycemia. Neuronal damage is indicated by pyknotic cells (H-E staining; green arrows) or with Fluoro-Jade B–positive cells (green fluorescence). Scale bar = 100 μm. C: Quantification of Fluoro-Jade B staining in CON-SH60 (white bar) (n = 6) and RH-SH60 (black bar) (n = 10) rats. Following severe hypoglycemia, RH rats had significantly fewer degenerating cells in the cortex than CON rats (*P < 0.05, by Student's t test). (A high-quality digital representation of this figure is available in the online issue.)
FIG. 2. Recurrent hypoglycemia attenuates brain damage after 60 min of severe hypoglycemia. A: Blood glucose levels are shown in rats subjected to a 60-min severe hypoglycemic (10–15 mg/dl) hyperinsulinemic (0.2 units · kg−1 · min−1) clamp. Blood glucose was not significantly different between CON-SH6 (open circles) (n = 6) and RH-SH60 (closed circles) (n = 10) rats during 60 min of severe hypoglycemia. B: Representative H-E (top panel) and Fluoro-Jade B–positive (bottom panel) staining of the cortex of CON-SH60 and RH-SH60 rats 1 week following 60 min of severe hypoglycemia. Neuronal damage is indicated by pyknotic cells (H-E staining; green arrows) or with Fluoro-Jade B–positive cells (green fluorescence). Scale bar = 100 μm. C: Quantification of Fluoro-Jade B staining in CON-SH60 (white bar) (n = 6) and RH-SH60 (black bar) (n = 10) rats. Following severe hypoglycemia, RH rats had significantly fewer degenerating cells in the cortex than CON rats (*P < 0.05, by Student's t test). (A high-quality digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 3. Recurrent hypoglycemia limits brain cell death 1 week following 90 min of severe hypoglycemia. A: Representative H-E staining of the cortex and hippocampal structures, CA1, and the dentate gyrus (DG), 1 week following 90-min severe hypoglycemic or euglycemic clamps in RH-SH90, RH-EUG, CON-SH90, and CON-EUG rats. Rats that underwent severe hypoglycemia had damaged neurons characterized by pyknotic nuclei (green arrows). Scale bar = 100 μm. B: Fluoro-Jade B–positive cells (green fluorescence) in the cortex, hippocampal CA1 region, and dentate gyrus of the same four treatment groups. Scale bar = 100 μm. C: Blood glucose was not significantly different between CON-SH90 (open circles) (n = 9) and RH-SH90 (closed circles) (n = 8) rats during 90 min of severe hypoglycemia. Blood glucose was clamped at equal levels of euglycemia in CON-EUG (open triangles) (n = 9) and RH-EUG (closed triangles) (n = 11) rats for 90 min. D: Following 90 min of severe hypoglycemia, the markedly increased number of FJB+ cells in the cortex, CA1, and dentate gyrus observed in the CON-SH90 rats (diagonal hatch) was significantly (*P < 0.05) reduced in RH-SH90 rats (gray horizontal hatch). Bars representing Fluoro-Jade B–positive cells in CON-EUG and RH-EUG groups are not visible in this figure because no appreciable brain damage was observed in euglycemic rats not exposed to severe hypoglycemia. E: CON-EUG and RH-EUG rats experienced no seizure-like behavior. Rats exposed to 90 min severe hypoglycemia exhibited seizure-like behavior, although RH-SH90 rats had significantly less seizure-like behavior than CON-SH90 rats (*P < 0.01). F: In rats that experienced severe hypoglycemia (RH-SH90 and CON-SH90), seizure-like behaviors positively correlated with the amount of Fluoro-Jade B cells in the hippocampus (R = 0.572; P < 0.05). (A high-quality digital representation of this figure is available in the online issue.)
FIG. 3. Recurrent hypoglycemia limits brain cell death 1 week following 90 min of severe hypoglycemia. A: Representative H-E staining of the cortex and hippocampal structures, CA1, and the dentate gyrus (DG), 1 week following 90-min severe hypoglycemic or euglycemic clamps in RH-SH90, RH-EUG, CON-SH90, and CON-EUG rats. Rats that underwent severe hypoglycemia had damaged neurons characterized by pyknotic nuclei (green arrows). Scale bar = 100 μm. B: Fluoro-Jade B–positive cells (green fluorescence) in the cortex, hippocampal CA1 region, and dentate gyrus of the same four treatment groups. Scale bar = 100 μm. C: Blood glucose was not significantly different between CON-SH90 (open circles) (n = 9) and RH-SH90 (closed circles) (n = 8) rats during 90 min of severe hypoglycemia. Blood glucose was clamped at equal levels of euglycemia in CON-EUG (open triangles) (n = 9) and RH-EUG (closed triangles) (n = 11) rats for 90 min. D: Following 90 min of severe hypoglycemia, the markedly increased number of FJB+ cells in the cortex, CA1, and dentate gyrus observed in the CON-SH90 rats (diagonal hatch) was significantly (*P < 0.05) reduced in RH-SH90 rats (gray horizontal hatch). Bars representing Fluoro-Jade B–positive cells in CON-EUG and RH-EUG groups are not visible in this figure because no appreciable brain damage was observed in euglycemic rats not exposed to severe hypoglycemia. E: CON-EUG and RH-EUG rats experienced no seizure-like behavior. Rats exposed to 90 min severe hypoglycemia exhibited seizure-like behavior, although RH-SH90 rats had significantly less seizure-like behavior than CON-SH90 rats (*P < 0.01). F: In rats that experienced severe hypoglycemia (RH-SH90 and CON-SH90), seizure-like behaviors positively correlated with the amount of Fluoro-Jade B cells in the hippocampus (R = 0.572; P < 0.05). (A high-quality digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 4. Antecedent recurrent hypoglycemia mitigated cognitive dysfunction induced by severe hypoglycemia. Morris water maze testing was performed 6–8 weeks following severe hypoglycemic or euglycemic clamps. A: During the cue trial, CON-SH90 rats (open circles) (n = 11) performed worse as evidenced by longer escape-path lengths than those of CON-EUG rats (open triangles) (n = 7) (aP = 0.002). Notably, rats exposed to recurrent moderate hypoglycemia before severe hypoglycemia (RH-SH90, n = 9 (closed circles) had shorter escape-path lengths than CON-SH90 rats (bP = 0.0025) and performed similarly to CON-EUG and RH-EUG rats (closed triangles) (n = 9). B: A similar pattern was observed during the place trials, where CON-SH90 rats had significantly higher escape-path lengths than CON-EUG (cP = 0.0001) and RH-SH90 (dP = 0.0006) rats. C: During the probe trial, CON-SH90 rats (diagonal hatch) had significantly fewer platform crossings than CON-EUG rats (white bar) (eP = 0.014). No significant differences were observed between CON-SH90 and RH-SH90 rats (gray horizontal hatch) or between CON-EUG and RH-EUG rats (black bar). D: RH-SH90, CON-EUG, and RH-EUG rats had a spatial bias toward the target quadrant while CON-SH90 rats did not (*P < 0.0025). E: During the probe trial, CON-SH90 rats showed an average proximity to the platform location that was significantly farther away than that of the CON-EUG rats (fP = 0.014). RH-SH90 rats swam significantly closer to the platform location than CON-SH90 rats (gP = 0.014)—similar to euglycemic controls. F: The number of episodes of seizure-like behaviors observed during severe hypoglycemia 6–8 weeks prior positively correlated with average path length during the place trials (R = 0.685; P < 0.001; n = 20).
FIG. 4. Antecedent recurrent hypoglycemia mitigated cognitive dysfunction induced by severe hypoglycemia. Morris water maze testing was performed 6–8 weeks following severe hypoglycemic or euglycemic clamps. A: During the cue trial, CON-SH90 rats (open circles) (n = 11) performed worse as evidenced by longer escape-path lengths than those of CON-EUG rats (open triangles) (n = 7) (aP = 0.002). Notably, rats exposed to recurrent moderate hypoglycemia before severe hypoglycemia (RH-SH90, n = 9 (closed circles) had shorter escape-path lengths than CON-SH90 rats (bP = 0.0025) and performed similarly to CON-EUG and RH-EUG rats (closed triangles) (n = 9). B: A similar pattern was observed during the place trials, where CON-SH90 rats had significantly higher escape-path lengths than CON-EUG (cP = 0.0001) and RH-SH90 (dP = 0.0006) rats. C: During the probe trial, CON-SH90 rats (diagonal hatch) had significantly fewer platform crossings than CON-EUG rats (white bar) (eP = 0.014). No significant differences were observed between CON-SH90 and RH-SH90 rats (gray horizontal hatch) or between CON-EUG and RH-EUG rats (black bar). D: RH-SH90, CON-EUG, and RH-EUG rats had a spatial bias toward the target quadrant while CON-SH90 rats did not (*P < 0.0025). E: During the probe trial, CON-SH90 rats showed an average proximity to the platform location that was significantly farther away than that of the CON-EUG rats (fP = 0.014). RH-SH90 rats swam significantly closer to the platform location than CON-SH90 rats (gP = 0.014)—similar to euglycemic controls. F: The number of episodes of seizure-like behaviors observed during severe hypoglycemia 6–8 weeks prior positively correlated with average path length during the place trials (R = 0.685; P < 0.001; n = 20).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 105

Metadata

Authors
Puente, E. C., Silverstein, J., Bree, A. J., Musikantow, D. R., Wozniak, D. F., Maloney, S., Daphna-Iken, D., & Fisher, S. J.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Fisher, Simon J.
Venue
Diabetes
Published
2010-01-19
Volume
59
Issue
4
Pages
1055-1062
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2113550419
Cited by
103
References
51
Citations by year
2026: 4 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 1 · 2020: 5 · 2019: 9 · 2018: 7 · 2017: 7 · 2016: 9 · 2015: 7 · 2014: 2 · 2013: 19 · 2012: 5
FWCI
8.96
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health (5p60dk020579-35)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK073683, DK 056341, R01DK073683, DK‐020579, P60-DK-020579, P30DK056341, P30DK020579)
  • National Institute of Neurological Disorders and Stroke (R01NS070235, P30NS057105, NS057105)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Clinical Neurology › Neurological and metabolic disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
severe hypoglycemia, cognitive impairment, spatial learning and memory, neuronal cell death, neuroprotection, hyperinsulinemic hypoglycemic clamp, insulin therapy, glycemic control
MeSH terms
Animals, Brain Death, Brain Injuries, Cognition Disorders, Humans, Hypoglycemia, Male, Memory, Motor Activity, Neurons, Recurrence, Seizures, Severity of Illness Index, Space Perception, Rats, Sprague-Dawley, Maze Learning, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.